One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ...

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

The Europe transgenic animal model market is set for robust growth, driven by surging biotechnology investments, demand for ...

Thanks to CRISPR, our medical specialists will soon have unprecedented control over how they treat and prevent some of our most challenging genetic disorders and diseases. CRISPR (Clustered Regularly ...

Changing an organism’s genome is a profound act, and the tools you use to make the changes don’t alleviate the need for responsible regulation. Unlike “traditional” genetically modified organisms (GMO ...

Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...

Rat disease models have played an integral role in scientific discovery and cancer research, including Nobel Prize–winning ...

These mutations improve biocontainment, transformation stability, and overall performance in genetic engineering of plants. Complementing the strains, researchers also developed new plasmids and a ...